Literature DB >> 11157602

Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia.

R Theerthakarai1, W El-Halees, M Ismail, R A Solis, M A Khan.   

Abstract

STUDY
OBJECTIVE: To assess the value of the initial microbiological studies (MBS), consisting of sputum Gram's stains, sputum cultures, and blood cultures, in the etiologic diagnosis of community-acquired pneumonia (CAP) without comorbidity.
DESIGN: A prospective study of 74 adult patients hospitalized with nonsevere CAP empirically treated according to the American Thoracic Society guidelines (ATS-GL) and evaluated with Gram's stains and cultures of valid sputum specimens and blood cultures.
SETTING: University-affiliated community hospital.
RESULTS: Gram's stain of a valid sputum specimen failed to identify the etiologic agent in all patients. Sputum cultures identified pathogens in only four patients (5%). The results of all blood cultures were negative. All patients responded to the initial empiric antibiotic coverage selected according to the ATS-GL, and the results of the initial MBS had no clinical impact.
CONCLUSION: The initial MBS, such as sputum Gram's stains, sputum cultures, and blood cultures, have no value in the management of nonsevere CAP without comorbid factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157602     DOI: 10.1378/chest.119.1.181

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  21 in total

1.  Utility of blood cultures in the management of adults with community acquired pneumonia discharged from the emergency department.

Authors:  S G Campbell; T J Marrie; R Anstey; S Ackroyd-Stolarz; G Dickinson
Journal:  Emerg Med J       Date:  2003-11       Impact factor: 2.740

Review 2.  Updated review of blood culture contamination.

Authors:  Keri K Hall; Jason A Lyman
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 3.  Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors:  K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

4.  Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; H M Jansen; W G Boersma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

5.  Blood cultures in ambulatory outpatients.

Authors:  Kevin B Laupland; Deirdre L Church; Daniel B Gregson
Journal:  BMC Infect Dis       Date:  2005-05-17       Impact factor: 3.090

6.  Factors associated with positive blood cultures in outpatients with suspected bacteremia.

Authors:  K Wildi; S Tschudin-Sutter; S Dell-Kuster; R Frei; H C Bucher; R Nüesch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-20       Impact factor: 3.267

7.  Utility of real-time PCR for diagnosis of Legionnaires' disease in routine clinical practice.

Authors:  Bram M W Diederen; Jan A J W Kluytmans; Christina M Vandenbroucke-Grauls; Marcel F Peeters
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

Review 8.  [Diagnostic procedures for patients with community acquired pneumonia].

Authors:  U Flückiger; M Battegay; G Laifer
Journal:  Internist (Berl)       Date:  2007-05       Impact factor: 0.743

9.  Can we predict which patients with community-acquired pneumonia are likely to have positive blood cultures?

Authors:  Samuel George Campbell; R Andrew McIvor; Vincent Joanis; David Graydon Urquhart
Journal:  World J Emerg Med       Date:  2011

10.  Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia.

Authors:  Remco P H Peters; Richard F de Boer; Tim Schuurman; Sonja Gierveld; Mirjam Kooistra-Smid; Michiel A van Agtmael; Christina M J E Vandenbroucke-Grauls; Maike C J Persoons; Paul H M Savelkoul
Journal:  J Clin Microbiol       Date:  2009-08-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.